Use of Urinary Tumor Cells and Circulating Tumor Cells (CTCs) in the Prognosis and Therapy of Patients With Bladder (BCa) and Upper Urinary Tract (UTUC) Cancer
Status: Recruiting
Location: See location...
Intervention Type: Genetic
Study Type: Observational
SUMMARY
The project aims to characterize the prognostic role of CTCs in Bladder cancer patients, with the specific aims to better stratify patients with non-muscle invasive bladder cancer at the first transurethral resection of tumor and to identify urothelial biomarker expressed by CTCs.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: t
View:
• Diagnosis of urothelial neoplasia, naive for therapy
Locations
Other Locations
Italy
Urology Department
RECRUITING
Milan
Contact Information
Primary
Massimo Alfano, PhD
alfano.massimo@hsr.it
+39022643
Backup
Chiara Venegoni, Dr.
venegoni.chiara@hsr.it
+39022643
Time Frame
Start Date: 2020-09-29
Estimated Completion Date: 2028-09-29
Participants
Target number of participants: 450
Treatments
1
Urothelial neoplasia
2
Age-matched individuals free of neoplasia
Related Therapeutic Areas
Sponsors
Leads: IRCCS San Raffaele